Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), and Segment Forecasts, 2019 - 2026

Published: Oct, 2019 | Pages: 110 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global intravenous (IV) iron drugs market size is expected to reach USD 2.90 billion by 2026,expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research. Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market. However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.

Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body. It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production. Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017. Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs. Furthermore, increasing healthcare expenditure and high accuracy, sensitivity and easy access of intravenous iron drugs fuels the market growth.

Among the products, the ferric carboxymaltose segment dominated the global intravenous iron drugs market in 2018 and is expected to grow significantly due to its increasing application in drug discovery processes, superior performance, and reduced cost. Ferric carboxymaltose is marketed as Injectafer in North America and under the name of Ferinject outside North America. Asia Pacific is projected to demonstrate the highest CAGR during the forecast period, while North America held the largest market share in 2018.

Further key findings from the study suggest:

• Among the applications, chronic kidney disease segment held the largest IV iron drugs market share in 2018, due to increasing prevalence and geriatric population

• Ferric carboxymaltose is expected to maintain its dominance through the forecast period due to the increasing application in drug discovery, superior performance and reduced cost

• Asia Pacific is projected to exhibit the fastest growth during the forecast period, which can be attributed to the increasing prevalence of chronic diseases in the region, improving healthcare infrastructure, and rising per capita healthcare expenditure

• Key players operating in the intravenous iron drugs market include Allergan, Inc.,AMAG Pharmaceuticals. Inc.,Daiichi Sankyo Company, Ltd., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, and American Regent. Inc.

 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market segmentation & scope
                   1.2 Market definition
                   1.3 Information procurement
                   1.4 Purchased database
                   1.5 GVR's internal database
                   1.6 Secondary sources & third party perspectives
                   1.7 Primary research
                   1.8 Information analysis
                   1.9 Data analysis models
                       1.10 Market formulation & data visualization
                   1.11 Data validation & publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Intravenous Iron Drugs Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Ancillary Market Outlook
                   3.2 Penetration and Growth Prospect Mapping
                   3.3 Regulatory Framework
                   3.4 Market Dynamics
                       3.4.1 Market driver analysis
                       3.4.2 Market restraint analysis
                       3.4.3 Industry challenges
                       3.4.4 Industry analysis - Porter's
                           3.4.4.1 Supplier Power
                           3.4.4.2 Buyer Power
                           3.4.4.3 Substitution Threat
                           3.4.4.4 Threat from new entrants
                           3.4.4.5 Competitive Rivalry
                       3.4.5 PESTEL Analysis
                           3.4.5.1 Political Landscape
                           3.4.5.2 Environmental Landscape
                           3.4.5.3 Social landscape
                           3.4.5.4 Technology landscape
                           3.4.5.5 Legal Landscape
                       3.4.6 Major deals and strategic alliances analysis
                           3.4.6.1 Joint ventures
                           3.4.6.2 Mergers and acquisitions
                           3.4.6.3 Licensing and partnership
                           3.4.6.4 Technology collaborations
                           3.4.6.5 Strategic Divestments
                       3.4.7 Market entry strategies
Chapter 4 Intravenous Iron Drugs Market - Competitive Analysis
                   4.1 Recent Developments & Impact Analysis, by Key Market Participants
                   4.2 Company Categorization
                   4.3 Vendor Landscape
                       4.3.1 List of key distributors and channel partners
                       4.3.2 Key customers
                       4.3.3 Key company market share analysis, 2018
                   4.4 Public Companies
                       4.4.1 Company market position analysis
                       4.4.2 Regional network map
                       4.4.3 Company market share, by region
                   4.5 Private Companies
                       4.5.1 List of key emerging companies
                       4.5.2 Company market position analysis
Chapter 5 Intravenous Iron Drugs Market: Product Estimates and Trend Analysis
                   5.1 Definition & Scope
                   5.2 Product Market Share Analysis, 2018 & 2026
                   5.3 Segment Dashboard
                   5.4 Global Intravenous Iron Drugs Market, by Product, 2015 to 2026
                   5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                       5.5.1 Iron Sucrose Market
                           5.5.1.1 Iron Sucrose Market, 2015 to 2026 (USD Million)
                       5.5.2 Iron Dextran Market
                           5.5.2.1 Iron Dextran Market, 2015 to 2026 USD Million)
                       5.5.3 Ferric Carboxymaltose Market
                           5.5.3.1 Ferric Carboxymaltose Market, 2015 to 2026 (USD Million)
                       5.5.4 Others Market
                           5.5.4.1 Others Market, 2015 to 2026 (USD Million)
Chapter 6 Intravenous Iron Drugs Market: Application Estimates and Trend Analysis
                   6.1 Definition & Scope
                   6.2 Application Market Share Analysis, 2018 & 2026
                   6.3 Segment Dashboard
                   6.4 Global Intravenous Iron Drugs Market, by Application, 2015 to 2026
                   6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
                       6.5.1 Chronic Kidney Disease Market
                           6.5.1.1 Intravenous Iron Drugs for Chronic Kidney Disease Market, 2015 to 2026 (USD Million)
                       6.5.2 Inflammatory Bowel Disease Market
                           6.5.2.1 Intravenous Iron Drugs for Inflammatory Bowel Disease Market, 2015 to 2026 (USD Million)
                       6.5.3 Cancer Market
                           6.5.3.1 Intravenous Iron Drugs for Cancer Market, 2015 to 2026 (USD Million)
                       6.5.4 Other Diseases Market
                           6.5.4.1 Intravenous Iron Drugs for Other Diseases Market, 2015 to 2026 (USD Million)
Chapter 7 Intravenous Iron Drugs Market: Regional Estimates & Trend Analysis
                   7.1 Regional Market Snapshot
                   7.2 Regional Market Share and Leading Players, 2018
                       7.2.1 North America
                       7.2.2 Europe
                       7.2.3 Latin America
                       7.2.4 Asia Pacific
                       7.2.5 Middle East & Africa
                   7.3 Market Share Analysis by Country, 2018
                       7.3.1 North America
                           7.3.1.1 U.S.
                           7.3.1.2 Canada
                       7.3.2 Europe
                           7.3.2.1 UK
                           7.3.2.2 Germany
                           7.3.2.3 Spain
                           7.3.2.4 France
                           7.3.2.5 Italy
                           7.3.2.6 Russia
                       7.3.3 Latin America
                           7.3.3.1 Brazil
                           7.3.3.2 Mexico
                           7.3.3.3 Argentina
                       7.3.4 Asia Pacific
                           7.3.4.1 Japan
                           7.3.4.2 China
                           7.3.4.3 India
                           7.3.4.4 South Korea
                           7.3.4.5 Singapore
                           7.3.4.6 Australia
                       7.3.5 Middle East & Africa
                           7.3.5.1 South Africa
                           7.3.5.2 Saudi Arabia
                           7.3.5.3 UAE
                   7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                       7.4.1 North America
                       7.4.2 Europe
                       7.4.3 Latin America
                       7.4.4 Asia Pacific
                       7.4.5 Middle East & Africa
                   7.5 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
                       7.5.1 North America
                           7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.1.2 U.S.
                               7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.1.3 Canada
                               7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       7.5.2 Europe
                           7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.2 UK
                               7.5.2.2.1 UK Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.3 Germany
                               7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.4 Spain
                               7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.5 France
                               7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.6 Italy
                               7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.2.7 Russia
                               7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       7.5.3 Asia Pacific
                           7.5.3.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.2 Japan
                               7.5.3.2.1 Japan Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.3 China
                               7.5.3.3.1 China Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.4 India
                               7.5.3.4.1 India Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.5 South Korea
                               7.5.3.5.1 South Korea Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.6 Singapore
                               7.5.3.6.1 Singapore Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.3.7 Australia
                               7.5.3.7.1 Australia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       7.5.4 Latin America
                           7.5.4.1 Latin America Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.4.2 Brazil
                               7.5.4.2.1 Brazil Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.4.3 Mexico
                               7.5.4.3.1 Mexico Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.4.4 Argentina
                               7.5.4.4.1 Argentina Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       7.5.5 Middle East & Africa
                           7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.5.2 South Africa
                               7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.5.3 Saudi Arabia
                               7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                           7.5.5.4 UAE
                               7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
Chapter 8 Company Profiles
                   8.1 Company Profiles
                       8.1.1 Allergan, Inc.
                           8.1.1.1 Company overview
                           8.1.1.2 Financial Performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 AMAG Pharmaceuticals. Inc.
                           8.1.2.1 Company overview
                           8.1.2.2 Financial Performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 Daiichi Sankyo Company, Ltd.
                           8.1.3.1 Company overview
                           8.1.3.2 Financial Performance
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 Sanofi
                           8.1.4.1 Company overview
                           8.1.4.2 Financial Performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 Fresenius Medical Care AG & Co.
                           8.1.5.1 Company overview
                           8.1.5.2 Financial Performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 Vifor Pharma Management Ltd.
                           8.1.6.1 Company overview
                           8.1.6.2 Financial Performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 Pharmacosmos A/S
                           8.1.7.1 Company overview
                           8.1.7.2 Financial Performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 Shield Therapeutics Plc
                           8.1.8.1 Company overview
                           8.1.8.2 Financial Performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 American Regent. Inc.
                           8.1.9.1 Company overview
                           8.1.9.2 Financial Performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies'/technology disruptors/innovators
Table 3 North America intravenous iron drugs market, by countries, 2015 - 2026 (USD Million)
Table 4 North America intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 5 North America intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 6 U.S. intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 7 U.S. intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 8 Canada intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 9 Canada intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 10 Europe intravenous iron drugs market, by countries, 2015 - 2026 (USD Million)
Table 11 Europe intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 12 Europe intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 13 Germany intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 14 Germany intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 15 UK intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 16 UK intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 17 France intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 18 France intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 19 Spain intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 20 Spain intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 21 Italy intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 22 Italy intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 23 Russia intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 24 Russia intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 25 Asia Pacific intravenous iron drugs market, by countries, 2015 - 2026 (USD Million)
Table 26 Asia Pacific intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 27 Asia Pacific intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 28 China intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 29 China intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 30 India intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 31 India intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 32 Japan intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 33 Japan intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 34 South Korea intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 35 South Korea intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 36 Singapore intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 37 Singapore intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 38 Australia intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 39 Australia intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 40 Latin America intravenous iron drugs market, by countries, 2015 - 2026 (USD Million)
Table 41 Latin America intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 42 Latin America intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 43 Brazil intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 44 Brazil intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 45 Mexico intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 46 Mexico intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 47 Argentina intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 48 Argentina intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 49 MEA intravenous iron drugs market, by countries, 2015 - 2026 (USD Million)
Table 50 MEA intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 51 MEA intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 52 South Africa intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 53 South Africa intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 54 Saudi Arabia intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 55 Saudi Arabia intravenous iron drugs market, by application, 2015 - 2026 (USD Million)
Table 56 UAE intravenous iron drugs market, by product, 2015 - 2026 (USD Million)
Table 57 UAE intravenous iron drugs market, by application, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Intravenous iron drugs market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Intravenous iron drugs market snapshot (2018)
Fig. 9 Intravenous iron drugs market: Segment snapshot (2018)
Fig. 10 Competitive Insights (2018)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Consumer behavior analysis
Fig. 16 Technology timeline
Fig. 17 Intravenous iron drugs market driver impact
Fig. 18 Intravenous iron drugs market restraint impact
Fig. 19 Porter's Five Forces Analysis
Fig. 20 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 21 Strategic alliance analysis
Fig. 22 Recent developments & impact analysis, by key market participants
Fig. 23 Key company market share analysis, 2018
Fig. 24 Company market share/ranking, by region
Fig. 25 Company market position analysis
Fig. 26 Supplier ranking
Fig. 27 Definition and scope, by product
Fig. 28 Product market share analysis, 2018 & 2026
Fig. 29 Segment dashboard
Fig. 30 Global intravenous iron drugs market, by product, 2015-2026 (USD Million)
Fig. 31 Iron sucrose market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 32 Iron dextran market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 33 Ferric carboxymaltose market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 34 Others market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 35 Global intravenous iron drugs market, by application, 2015-2026 (USD Million)
Fig. 36 Chronic kidney disease market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 37 Inflammatory bowel disease market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 38 Cancer market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 39 Other diseases market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 40 Intravenous iron drugs market: Snapshot, 2018
Fig. 41 North America intravenous iron drugs market share and leading players, 2018
Fig. 42 Europe intravenous iron drugs market share and leading players, 2018
Fig. 43 Asia Pacific intravenous iron drugs market share and leading players, 2018
Fig. 44 Latin America intravenous iron drugs market share and leading players, 2018
Fig. 45 Middle East and Africa intravenous iron drugs market share and leading players, 2018
Fig. 46 North America intravenous iron drugs market share analysis by country, 2018
Fig. 47 Europe intravenous iron drugs market share analysis by country, 2018
Fig. 48 Asia Pacific intravenous iron drugs market share analysis by country, 2018
Fig. 49 Latin America intravenous iron drugs market share analysis by country, 2018
Fig. 50 Middle East and Africa intravenous iron drugs market share analysis by country, 2018
Fig. 51 North America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 52 Europe SWOT analysis, by factor (political & legal, economic and technological)
Fig. 53 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
Fig. 54 Latin America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 55 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Fig. 56 North America intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 57 U.S. intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 58 Canada intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 59 Europe intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 60 UK intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 61 Germany intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 62 Spain intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 63 France intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 64 Italy intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 65 Russia intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 66 Asia Pacific intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 67 China intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 68 Japan intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 69 India intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 70 South Korea intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 71 Singapore intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 72 Latin America intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 73 Brazil intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 74 Mexico intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 75 Argentina intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 76 Middle East and Africa intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 77 South Africa intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 78 Saudi Arabia intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 79 UAE intravenous iron drugs market size & forecasts and trend analysis, 2015 to 2026 (USD Million)